What are appropriate treatment intervals for late latent syphilis or syphilis of unknown duration in non-pregnant people?
Prepared by the STD Control Branch, California Department of Public Health and California Prevention Training Center. Revised February 2023.
January 18, 2023, 11:30 AM-12:45 PM (PST)
Presented by Dr. Lindley Barbee
This webinar will focus on an update of the clinical and epidemiologic aspects of Mycoplasma genitalium.
Learning Objectives:
This resource from the California Department of Public Health and California Prevention Training Center provides a concise, gender-specific summary of recommended STI screening practices.
Download the California STI Screening Recommendations.
Tuesday, December 6, 2022 from 12:00PM-1:15PM (PST)
Presented by Drs. Kathleen Jacobson and Kelly Johnson
A case-based approach to recognizing sexually transmitted infections, with a focus on those that disseminate outside the genital tract.
Learning Objectives
October 18, 2022
Presented by Drs. Rosalyn Plotzker, Akanksha Vaidya, and Eric Tang
The California Department of Public Health (CDPH) continues to see statewide increases in all reportable sexually transmitted infections (STIs), including syphilis, gonorrhea and chlamydia.
For many patients, these STIs manifest as a complex syndrome that involves local and systemic symptoms. This webinar is the first of a two-part series, featuring Drs. Rosalyn Plotzker,
Akanksha Vaidya, and Eric Tang of the CDPH Sexually Transmitted Diseases Control Branch who will lead a case-based discussion on the presentation, diagnosis and syndromic management of STIs.
Learning Objectives
Providing guidance on the traditional screening algorithm and reverse screening algorithm.
Excellent FAQs and resources from Building Healthy Online Communities on the latest in mpox (formerly known as monkeypox) prevention, transmission, symptoms, and treatment. Updated regularly.
August 17, 2022
Description:
Since the first HPV vaccines were introduced in 2006, rates of cervical cancer and other HPV-related cancers have decreased in immunized populations. Family PACT will add HPV immunization as a benefit in July 2022 and will utilize guidelines developed by the CDC Advisory Committee of Immunization Practices (ACIP). This webinar will provide information about the effectiveness and safety of the HPV vaccine, review the current CDC recommendations for the use of the 9-valent HPV vaccine, and provide advice on how to have effective shared decision-making conversations with clients about being immunized. In addition, new Family PACT policies about coding and billing for HPV immunization services will be discussed. There will be ample time for your questions at the end of the presentation.
Learning Objectives:
• List 2 effective strategies for engaging with patients who have vaccine hesitancy
• Demonstrate a person-centered technique for providing a strong recommendation without coercion
• Describe the impact of HPV vaccination on the natural history of HPV
• Discuss the safety profile of HPV vaccines
Speakers:
Assistant Clinical Professor
UCLA School of Nursing
President, Envision SRH
Professor Emeritus, UCSF
Senior Medical Advisor, CAPTC and California OFP
Clinical Fellow, NFPRHA
Resources:
Transcript: Talking with Family PACT Clients About HPV Immunization
Slide deck: Talking with Family PACT Clients About HPV Immunization
Q and A: Talking with Family PACT Clients About HPV Immunization
CDC guidance intended for people who have had mpox exposures in the community. Includes who should be monitored, what to monitor, and how to monitor.
See also: Infection Prevention and Control of Monkeypox in Healthcare Settings.
Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with treatable sexually transmitted infections (STIs) – including chlamydia, gonorrhea, and trichomoniasis – without the health care provider first examining the partner(s).
This document explains what EPT is and why clinicians in California should prescribe it. In-depth references are also provided.
